Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

How to distinguish between hypertrophic cardiomyopathy and left ventricular hypertrophy secondary to Fabry disease?

View through CrossRef
Abstract Introduction Fabry disease (FD) commonly leads to left ventricular hypertrophy (LVH) that could mimic sarcomeric hypertrophic cardiomyopathy (HCM). Purpose To determine the differences in echocardiographic parameters between FD patients with LVH and HCM patients. Methods We conducted a prospective study encompassing FD patients followed in a Reference Center of Lysosomal Storage Disorders. All patients performed a complete echocardiographic evaluation, including left ventricular strain analysis by two-dimensional speckle tracking imaging. Demographic, clinical characteristics and echocardiographic parameters were analysed. FD patients with LVH were compared with HCM patients, using Chi-square test for categorical variables and Student's T-test for continuous variables. The significance level was 0,05. Results A total of 91 FD patients were included, with a median age of 51 years-old and 62,6% of female predominance. 16,5% of patients were under enzymatic replacement therapy with agalsidase alpha and 7,7% were treated with chaperone therapy (migalastat). 33 FD patients (36%) had LVH and were older than HCM patients (63,6 vs 59,3 years-old; p=0,106). FD patients with LVH had lower interventricular septum (IVS) thickness (16,4 vs 19,6 mm, p<0,001), IVS/posterior wall ratio (1,3 vs 1,8, p<0,001), and left atrial volume index (34,45 vs 42,2 ml/m2; p=0,014). Left ventricle mass index was similar between the two groups (157,7 vs 155,5 g/m2; p=0,819), with lower left ventricular ejection fraction in FD patients (64,5% vs 70,5%; p<0,001). There were no significant differences in global longitudinal strain (−15,6% vs 15,9%; p=0,687), global circumferential strain (−19,9% vs −21,1%; p=0,218) and global radial strain (35,3% vs 33,7%; p=0,623). Interestingly, FD patients had lower base-to-apex circumferential strain gradient (5,7% vs 9,1%; p=0,002) and lower twist (17,5° vs 26,1°; p=0,001) than HCM patients. No significant differences were reported regarding mechanical dispersion (72,4 vs 71,2 ms; p=0,841). Conclusion The pattern of LVH is different between FD and HCM patients. In our study, we revealed that base-to-apex circumferential strain gradient and twist are echocardiographic parameters that could help distinguish both entities. Funding Acknowledgement Type of funding sources: None.
Title: How to distinguish between hypertrophic cardiomyopathy and left ventricular hypertrophy secondary to Fabry disease?
Description:
Abstract Introduction Fabry disease (FD) commonly leads to left ventricular hypertrophy (LVH) that could mimic sarcomeric hypertrophic cardiomyopathy (HCM).
Purpose To determine the differences in echocardiographic parameters between FD patients with LVH and HCM patients.
Methods We conducted a prospective study encompassing FD patients followed in a Reference Center of Lysosomal Storage Disorders.
All patients performed a complete echocardiographic evaluation, including left ventricular strain analysis by two-dimensional speckle tracking imaging.
Demographic, clinical characteristics and echocardiographic parameters were analysed.
FD patients with LVH were compared with HCM patients, using Chi-square test for categorical variables and Student's T-test for continuous variables.
The significance level was 0,05.
Results A total of 91 FD patients were included, with a median age of 51 years-old and 62,6% of female predominance.
16,5% of patients were under enzymatic replacement therapy with agalsidase alpha and 7,7% were treated with chaperone therapy (migalastat).
33 FD patients (36%) had LVH and were older than HCM patients (63,6 vs 59,3 years-old; p=0,106).
FD patients with LVH had lower interventricular septum (IVS) thickness (16,4 vs 19,6 mm, p<0,001), IVS/posterior wall ratio (1,3 vs 1,8, p<0,001), and left atrial volume index (34,45 vs 42,2 ml/m2; p=0,014).
Left ventricle mass index was similar between the two groups (157,7 vs 155,5 g/m2; p=0,819), with lower left ventricular ejection fraction in FD patients (64,5% vs 70,5%; p<0,001).
There were no significant differences in global longitudinal strain (−15,6% vs 15,9%; p=0,687), global circumferential strain (−19,9% vs −21,1%; p=0,218) and global radial strain (35,3% vs 33,7%; p=0,623).
Interestingly, FD patients had lower base-to-apex circumferential strain gradient (5,7% vs 9,1%; p=0,002) and lower twist (17,5° vs 26,1°; p=0,001) than HCM patients.
No significant differences were reported regarding mechanical dispersion (72,4 vs 71,2 ms; p=0,841).
Conclusion The pattern of LVH is different between FD and HCM patients.
In our study, we revealed that base-to-apex circumferential strain gradient and twist are echocardiographic parameters that could help distinguish both entities.
Funding Acknowledgement Type of funding sources: None.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Background: Coronary flow with a diastolic predominance increases two to five times in hyperemia, mediated by vasodilation (coronary flow reserve, CFR) and, in hypertrophy, relativ...
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiac amyloidosis was long considered a rare disease, primarily affecting the elderly. However, recent studies have demonstrated a higher prevalence, highlighting the need for fu...
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
Background Takotsubo cardiomyopathy, also known as stress cardiomyopathy and broken heart syndrome, is a transient, non-ischemic cardiomyopathy marked by revers...
Current management of hypertrophic cardiomyopathy
Current management of hypertrophic cardiomyopathy
ABSTRACT Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients m...
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Abstract BackgroundApical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy that predominantly affects the left ventricle apex and rarely involves the...
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
ABSTRACT. Eriksson P, Backman C, Eriksson A, Eriksson S, Karp K, Olofsson B‐O (Departments of Internal Medicine, Geriatric Medicine, and Clinical Physiology, University Hospital, ...

Back to Top